Supplementary Indent For 2024 25 Tdm 1 (ado Trastuzumab Emtansine) Inj 100mg
Tender Title | Supplementary Indent For 2024 25 Tdm 1 (ado Trastuzumab Emtansine) Inj 100mg | ||
Tender ID | NA | Tender Reference Number | 82241030L |
Tender Type | Open/advertised | ||
Tender Opening Date | 2024-09-27 06:58 AM | Tender Closing Date | 2024-10-21 05:30 AM |
Tender Value | Refer Document | Tender Location | New Delhi , Central Delhi , Delhi |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2024-09-27 06:58 AM | Bid Opening Date | 2024-10-21 05:30 AM |
Document Download Start Date | 2024-09-27 06:58 AM | Document Download End Date | 2024-10-21 05:30 AM |
Bid Submission Start Date | 2024-09-27 06:58 AM | Bid Submission End Date | 2024-10-21 05:30 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | NA |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | ₹ 73,660 |
EMD Fee Type | NA |
Payment Instruments/Mode | NA |
Work Description - For Complete Deion And Other Details, Please Refer To Tender
The Ministry of Railways, Stores/Northern Rly, is inviting bids for the supply of TDM-1 (Ado-Trastuzumab Emtansine) Inj 100mg under Tender Reference Number 82241030L. This open tender, categorized as "Goods" and falling under the "Railway related Products" category, seeks to fulfill a supplementary indent for the 2024-25 fiscal year. Interested bidders are encouraged to download the tender documents from the official platform starting on September 27th, 2024, 12:28 PM. Bids can be submitted between September 27th, 2024, 12:28 PM, and October 21st, 2024, 11:00 AM, with the bid opening scheduled for the same date and time. The tender requires an Earnest Money Deposit (EMD) of ₹73,660 and no tender fee is applicable. For detailed specifications and further information, please refer to the tender document.
Get Hassle free financing for your business
Office Inviting Bids | Stores/northern Rly |
Address | 2nd Floor, Annexe- I Baroda House, K G Marg New Delhi |
Contact Details | NA |
NA | |
Website | NA |
Supplementary Indent For 2024-25 Inj. Panitumumab 100mg..read more
Supplementary Indent For 2024-25 Cap/tab Empagliflozin 25mg..read more
Supplementary Indent For 2024-25 Tab/cap Linagliptin 5mg..read more
(ami No. 8.103) (2024-25) Tab/cap Paracetamol 650mg (supplementary Indent)..read more
Inj Progesterone 100mg/ml..read more
All the major brands in each raw material category